Elifcan Aladağ

The effects of blood group types on the risk of COVID-19 infection and its clinical outcome

Hakan Göker, Elifcan Aladağ, Halûk Demiroğlu et al. · TURKISH JOURNAL OF MEDICAL SCIENCES · 2020 · 208 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +17

A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects

Deniz Çağdaş, Sevil Oskay Halaçlı, Çağman Tan et al. · Journal of Clinical Immunology · 2019 · 59 citations · Full text

Medicine, Pathology, Molecular Pathology +4

Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis

Olgu Erkin Çınar, Elifcan Aladağ, Ayşe Karataş et al. · Transfusion and Apheresis Science · 2020 · 45 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013

Pınar Zarakolu, Özgen Köseoğlu Eser, Elifcan Aladağ et al. · Diagnostic Microbiology and Infectious Disease · 2016 · 43 citations

Life Sciences, Infectious Diseases, Microbiology +16

Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19

Elifcan Aladağ, Zahit Taş, Bilgesu Şafak Tümerdem et al. · Journal of the Renin-Angiotensin-Aldosterone System · 2021 · 34 citations · Full text

Medicine, Immunology, Molecular Genetics +11